Suchergebnisse - "Duyster, Justus"

PubPharm (21)

1

Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib

enthalten in: Cancer | 2014

von Joensuu, H. | Eriksson, M. | Hall, K. | +17

2

Sequential inhibitor therapy in CML : in vitro simulation elucidates the pattern of resistance mutations after second- and third-line treatment

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2013

von Bauer, R. | Sänger, J. | Peschel, C. | +2

3

One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor : a randomized trial

enthalten in: JAMA | 2012

von Joensuu, H. | Eriksson, M. | Sundby Hall, K. | +20

CommentIn: JAMA. 2012 Mar 28;307(12):1312-4. - PMID 22453573

4

Efficacy and safety of motesanib, an oral inhibitor of VEGF, PDGF, and Kit receptors, in patients with imatinib-resistant gastrointestinal stromal tumors

enthalten in: Cancer chemotherapy and pharmacology | 2011

von Benjamin, R. | Schöffski, P. | Hartmann, J. | +12

5

Activity and tolerability of nilotinib : a retrospective multicenter analysis of chronic myeloid leukemia patients who are imatinib resistant or intolerant

enthalten in: Cancer | 2010

von Koren-Michowitz, M. | le Coutre, P. | Duyster, J. | +7

ErratumIn: Cancer. 2011 Jan 1;117(1):230

6

T-cell lymphoproliferative disorder potentially induced by imatinib in a patient with GIST

enthalten in: Nature reviews. Clinical oncology | 2010

von Verbeek, M. | Fend, F. | Licht, T. | +4

7

Chronic myelogenous leukemia : treatment and monitoring

enthalten in: Deutsches Arzteblatt international | 2010

von von Bubnoff, N. | Duyster, J.

8

Imatinib and leptomycin B are effective in overcoming imatinib-resistance due to Bcr-Abl amplification and clonal evolution but not due to Bcr-Abl kinase domain mutation

enthalten in: Haematologica | 2008

von Kancha, R. | von Bubnoff, N. | Miething, C. | +3

9

The immunogenicity of Bcr-Abl expressing dendritic cells is dependent on the Bcr-Abl kinase activity and dominated by Bcr-Abl regulated antigens

enthalten in: Blood | 2007

von Scheich, F. | Duyster, J. | Peschel, C. | +1

10

Retroviral insertional mutagenesis identifies RUNX genes involved in chronic myeloid leukemia disease persistence under imatinib treatment

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2007

von Miething, C. | Grundler, R. | Mugler, C. | +7